RecruitingNCT02938611

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

3,375 participants

Start Date

Jan 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study surveys and analyzes how advanced chronic kidney disease (CKD) — severe long-term kidney damage — is identified and managed in the Gard region of France, to understand how many people have this condition and whether they are receiving appropriate care. **You may be eligible if...** - You have been diagnosed with stage 4 or higher chronic kidney disease (meaning your kidneys are functioning at less than 30% of normal capacity) **You may NOT be eligible if...** - No specific exclusion criteria have been listed for this study This is a population-level research study that helps public health officials understand gaps in care for kidney disease patients in France. Your participation contributes to improving healthcare systems for people with kidney disease. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

AIDER - Unité de Dialyse d'Alès

Alès, France

AIDER - Unité de Dialyse de Nîmes, CHU Carémeau

Nîmes, France

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, France

Gardialyse

Nîmes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02938611


Related Trials